Head-to-head · computed 2026-08-11
Gala GLP-1 vs TMates
Gala GLP-1: Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149. TMates: TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife.
Tirzepatide
| Gala GLP-1 | TMates | |
|---|---|---|
| All-in maintenance | $179/mo | $297/mo |
| Best plan rate | $179/mo | $167/mo |
| 12-month total | $2,148 | $2,004 |
| Status | Reported · 2026-07-14 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts TMates's $297 by $118 a month at the 10 mg/wk maintenance basis — $1,416 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and TMates's is reported (captured 2026-07-14); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Gala GLP-1's tirzepatide ladder runs $179 a month billed monthly, and $199 a month on a three-month plan. TMates's runs $297 a month billed monthly, and $167 a month on a twelve-month plan. On the twelve-month basis TMates's $2,004 beats Gala GLP-1's $2,148 by $144 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| Gala GLP-1 | TMates | |
|---|---|---|
| All-in maintenance | $179/mo | $249/mo |
| Best plan rate | $179/mo | $158/mo |
| 12-month total | $2,148 | $1,896 |
| Status | Reported · 2026-07-14 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts TMates's $249 by $70 a month at the 2.4 mg/wk maintenance basis — $840 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and TMates's is reported (captured 2026-07-14); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Gala GLP-1's semaglutide ladder runs $179 a month billed monthly, and $199 a month on a three-month plan. TMates's runs $249 a month billed monthly, and $158 a month on a twelve-month plan. On the twelve-month basis TMates's $1,896 beats Gala GLP-1's $2,148 by $252 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
On dose economics, Gala GLP-1 is dose-flat — the price survives titration — while TMates's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
Gala GLP-1
- MembershipNone
- Dose policyFlat at 'all doses' for standard plan; separate microdosing tier at $149
- Commitment3-month plan or standard monthly; confirm exact terms at enrollment
- CancellationPer provider terms
- PharmacyPartner 503A pharmacies (not named publicly)
TMates
- MembershipNone
- Dose policyStructured titration; medication and provider visits included in price
- Commitment12-month plan or month-to-month; substantial difference in rates
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
What our desk is watching on each
Gala GLP-1: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
TMates: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Questions people ask
Is Gala GLP-1 or TMates cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Gala GLP-1 vs TMates miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Gala GLP-1 and TMates cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $2,148 at Gala GLP-1 and $2,004 at TMates — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Gala GLP-1 · TMates. Official sites: Gala GLP-1 ↗ · TMates ↗. Nothing here is medical advice.